SCHEMBL17437974

SCHEMBL17437974

CCc1cccc2nnc(C(=O)O)n12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.41
GRIN1 Q05586 2/20 0.38
GRIN2A Q12879 2/20 0.38
PDE5A O76074 1/20 0.32
NR4A3 Q92570 1/20 0.32
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
GABRB2 P47870 1/20 0.32
GABRA4 P48169 1/20 0.32
GABRE P78334 1/20 0.32
GABRA6 Q16445 1/20 0.32
GABRG1 Q8N1C3 1/20 0.32
GABRG3 Q99928 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18323661 0.74 POLB (0.47) POLBGRIN1GRIN2AMEN1KMT2A
SCHEMBL17580692 0.72 MAPK1 (0.43) GRIN1GRIN2APDE5AKMT2AALDH1A1
SCHEMBL15907079 0.70 MEN1 (0.60) POLBGRIN1GRIN2APDE5AMEN1
SCHEMBL1582221 0.69 GRIN1 (0.44) POLBGRIN1GRIN2APDE5AMAPT
SCHEMBL18131842 0.68 GRIN1 (0.39) GRIN1GRIN2APDE5ANR4A3GABRP
SCHEMBL18131803 0.68 GRIN1 (0.39) GRIN1GRIN2APDE5ANR4A3GABRP
SCHEMBL14736601 0.67 PDE10A (0.42) GRIN1GRIN2AMEN1KMT2ARAB9A
SCHEMBL7277074 0.67 GAA (0.50) GRIN1GRIN2AMAPTRAB9ASMN1; SMN2
SCHEMBL12549863 0.67 HDAC4 (0.34) POLBGRIN1GRIN2ANR4A3GABRP
SCHEMBL18323674 0.63 POLB (0.60) POLBMEN1KMT2ACHEK1LTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9902702-B2 Spirocycloheptanes as inhibitors of rock BRISTOL-MYERS SQUIBB COMPANY (US) 2018-02-27 US disclosed
US-20160016914-A1 SPIROCYCLOHEPTANES AS INHIBITORS OF ROCK BRISTOL-MYERS SQUIBB COMPANY 2016-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160016914-A1 SPIROCYCLOHEPTANES AS INHIBITORS OF ROCK ROCK1, MYLK, ROCK2 POLB 4459/4885GRIN1 2538/4885GRIN2A 3632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.